Liposarcoma metastatic – Life with Disease

Go back

Metastatic liposarcoma is a rare and serious form of cancer that occurs when liposarcoma, a tumor that begins in fat cells, spreads from its original location to other parts of the body. Understanding what to expect when the disease progresses, how it affects daily life, and what support families need during clinical trial participation can help patients and their loved ones navigate this challenging journey with greater clarity and confidence.

Prognosis and Survival Outlook

When liposarcoma spreads beyond its original site, the outlook becomes more challenging. The prognosis for metastatic liposarcoma varies significantly depending on which subtype of the disease a person has, as each behaves very differently once it reaches other organs or tissues[4].

Generally speaking, patients with metastatic soft tissue sarcomas, including liposarcoma, face a difficult situation. Studies show that the median survival, which means the point at which half of patients are still living, is typically around 12 to 17 months after the cancer has spread[9][19]. However, these are just averages, and individual experiences can differ greatly.

The type of liposarcoma makes an enormous difference in predicting outcomes. Well-differentiated liposarcoma, even when it occurs in difficult locations, does not have the ability to spread to distant organs and therefore cannot become truly metastatic[5]. Dedifferentiated liposarcoma, which can develop from well-differentiated tumors, is more aggressive and capable of spreading, primarily to the lungs[5][8]. Myxoid-round cell liposarcoma has unusual spreading patterns, often moving to places like the spine, areas of fat around the body, and the retroperitoneum rather than just the lungs[5][6]. Pleomorphic liposarcoma is the most aggressive subtype, spreading early and having the poorest prognosis overall[5].

Several factors influence how long someone might live with metastatic liposarcoma. The tumor’s grade, which describes how abnormal the cells look under a microscope and how quickly they might grow, plays a significant role[6]. The location of the original tumor matters too. Whether the cancer has already spread to multiple organs or remains in just one site, and how well someone responds to treatment, all contribute to the overall outlook.

⚠️ Important
While statistical averages provide useful information for understanding the general course of metastatic liposarcoma, every person’s cancer is unique. Your individual prognosis depends on many factors including your specific subtype, your overall health, how your body responds to treatment, and new therapies that may become available. Having honest conversations with your medical team about your specific situation is essential for understanding what to expect.

Natural Progression Without Treatment

If metastatic liposarcoma is left untreated, the disease will continue to grow and spread, causing increasingly serious problems throughout the body. The cancer cells will multiply in the locations where they have already settled and may continue traveling to new organs and tissues[16].

The most common site for liposarcoma to spread is the lungs. In fact, about half of all patients with high-grade soft tissue sarcomas eventually develop lung metastases, and in about 70% of these cases, the lungs remain the only organ affected by distant spread[19]. This happens because cancer cells break away from the original tumor, enter the bloodstream, and eventually lodge in the tiny blood vessels of the lungs.

Without treatment, tumors in the lungs will grow larger over time. As they expand, they take up space that healthy lung tissue would normally occupy. This leads to difficulty breathing, persistent coughing, and eventually severe respiratory problems. A person might notice they become short of breath even during simple activities like walking across a room or climbing a few stairs.

Some types of liposarcoma spread in unusual patterns. Myxoid-round cell liposarcoma, for instance, has a tendency to spread to soft tissue areas, bones including the spine and pelvis, and even organs like the heart or esophagus[4][6]. When cancer reaches these locations, it can interfere with their normal function in various ways.

The primary tumor site also continues growing if left untreated. Local growth can cause significant problems depending on where the original tumor is located. A tumor in the abdomen might press on the intestines, stomach, or other organs, leading to pain, digestive problems, and swelling. A tumor in the limbs might compress nerves and blood vessels, causing pain, numbness, weakness, and swelling of the affected arm or leg.

As the disease progresses without treatment, people often experience worsening general symptoms. These can include unintended weight loss, loss of appetite, profound fatigue that doesn’t improve with rest, fever, night sweats, and an overall sense of feeling unwell[7]. The body is fighting the cancer, and this takes a tremendous toll on energy and resources.

Eventually, without treatment, the cancer will spread more widely throughout the body, affecting multiple organ systems and causing life-threatening complications. This is why early detection and treatment are so important, even though metastatic disease remains challenging to manage.

Possible Complications

Metastatic liposarcoma can lead to numerous complications, some related to the cancer itself and others arising from treatments. Understanding these potential problems helps patients and families recognize warning signs and seek help promptly.

One of the most serious complications occurs when tumors in the lungs grow large enough to significantly interfere with breathing. This can lead to respiratory failure, where the lungs can no longer provide the body with enough oxygen or remove carbon dioxide effectively. This is a medical emergency requiring immediate care[4].

When liposarcoma spreads to bones, particularly the spine, it can cause severe complications. Tumors in the spinal column may press on the spinal cord or the nerves that branch off from it. This compression can cause intense pain, numbness, tingling, weakness in the arms or legs, and in severe cases, paralysis or loss of bowel and bladder control[6]. These symptoms require urgent medical attention.

Large tumors in the abdomen can cause bowel obstruction, where the intestines become partially or completely blocked. This leads to severe abdominal pain, bloating, inability to pass stool or gas, vomiting, and potentially dangerous fluid and electrolyte imbalances. A complete bowel obstruction is a surgical emergency.

Bleeding is another potential complication. Tumors can erode into blood vessels, causing internal bleeding. In the digestive tract, this might show up as blood in vomit or stool[7]. Significant blood loss can lead to anemia, causing weakness, fatigue, dizziness, and shortness of breath.

Local recurrence is a significant concern with liposarcoma, even many years after the original tumor was removed. Studies show that well-differentiated liposarcoma has a local recurrence rate of about 10%, and these recurrences can happen even 25 years after the initial surgery[2]. When well-differentiated liposarcoma recurs, there is also a risk that it will transform into dedifferentiated liposarcoma, which is more aggressive and capable of metastasis[8][13].

Dedifferentiated liposarcoma has a particularly high recurrence rate, with studies showing that 40 to 75% of cases come back after treatment, and about 10 to 15% of patients develop metastases[8]. Each recurrence makes the cancer harder to treat and increases the risk of further spread.

Treatment itself can cause complications. Surgery to remove large tumors may result in infection, bleeding, or damage to nearby structures. Chemotherapy can lower white blood cell counts, increasing the risk of serious infections, and may cause nausea, fatigue, and damage to organs like the heart or kidneys. Radiation therapy can cause skin changes, fatigue, and damage to healthy tissues in the treatment area.

Pain is a common complication as the disease progresses. Tumors pressing on nerves, bones, or organs can cause severe, chronic pain that requires careful management with medications and other approaches. This pain can significantly affect quality of life and daily functioning.

Metabolic complications can occur as well. Cancer can cause high calcium levels in the blood, called hypercalcemia, which leads to confusion, extreme thirst, frequent urination, constipation, and in severe cases, coma. The body’s metabolism becomes disrupted as cancer cells consume nutrients and produce waste products.

Impact on Daily Life

Living with metastatic liposarcoma affects nearly every aspect of daily existence, from physical capabilities to emotional well-being, social relationships, work life, and the activities that once brought joy and meaning.

Physically, the disease and its treatments can be exhausting. Many people describe a kind of fatigue that is different from normal tiredness—it doesn’t improve with rest and can make even simple tasks feel overwhelming. Getting dressed, preparing meals, or taking a shower might require rest breaks. This fatigue can be frustrating for people who were previously active and independent.

Pain is another physical challenge that can significantly limit activity. Depending on where tumors are located, pain might be constant or might flare up with certain movements. Some people find they need to modify how they move through the day, perhaps using assistive devices like canes or walkers, or rearranging their living space to minimize stairs and long distances.

If the cancer has spread to the lungs, breathing difficulties can be particularly limiting. Activities that once felt easy, like walking to the mailbox or carrying groceries, might now leave someone gasping for breath. This can lead to a gradual narrowing of one’s world as people limit their activities to avoid breathlessness.

Emotionally, a diagnosis of metastatic cancer brings intense feelings that may come and go in waves. Fear about the future, anxiety about symptoms and treatments, sadness about losses and changes, and anger about the unfairness of the situation are all normal responses. Some days might feel manageable, while others bring overwhelming emotions. Many people find that talking with a counselor, therapist, or support group helps them process these feelings.

Relationships often shift when someone is living with metastatic cancer. Family members and friends may not know how to help or what to say, leading to awkward interactions or even avoidance. On the other hand, some relationships deepen as loved ones rally around to provide support. Partners may need to take on new roles, such as managing household tasks that the patient can no longer do or attending medical appointments. These changes can create both strain and closeness.

Work life is frequently affected. Some people with metastatic liposarcoma continue working, perhaps with reduced hours or modified duties, finding that work provides a sense of purpose and normalcy. Others need to stop working entirely, either because of physical limitations, treatment schedules, or the unpredictability of symptoms. This can bring financial stress as well as the loss of professional identity and daily structure.

Hobbies and activities that once brought pleasure might need to be adapted or abandoned. Someone who loved gardening might need to switch to container gardening that doesn’t require kneeling or heavy lifting. An avid hiker might need to find enjoyment in shorter, gentler walks or in appreciating nature from a seated position. Finding new ways to experience joy and meaning becomes important.

Medical appointments, treatments, and managing side effects can take up considerable time and energy. The logistics of getting to appointments, waiting for tests, undergoing treatments, and managing medications can feel like a part-time job. This leaves less time and energy for other aspects of life.

Some practical strategies can help manage these impacts. Breaking tasks into smaller steps and resting between them can help conserve energy. Using community resources like meal delivery services, transportation assistance, or home care services can reduce burden. Staying connected with others through phone calls, video chats, or visits when feeling up to it helps combat isolation. Finding moments of joy, whether through music, nature, time with loved ones, or spiritual practices, provides emotional sustenance.

Many people find that shifting focus from what they can no longer do to what remains possible helps maintain a sense of purpose and quality of life. This might mean setting smaller, achievable goals for each day rather than thinking far into an uncertain future.

Support for Families During Clinical Trials

Clinical trials represent an important avenue for accessing new treatments for metastatic liposarcoma. For families, understanding how to support a loved one through the clinical trial process can make a significant difference in both the patient’s experience and the trial’s success.

First, families should understand what clinical trials are and why they matter. Clinical trials are carefully designed research studies that test new treatments to see if they are safe and effective. For metastatic liposarcoma, where standard treatment options may have limited effectiveness, clinical trials offer access to innovative therapies that aren’t yet widely available[12]. These might include new chemotherapy drugs, targeted therapies that attack specific features of cancer cells, or combinations of treatments that haven’t been tested before.

The decision to participate in a clinical trial is deeply personal and requires careful consideration. Family members can help by participating in discussions with the medical team, asking questions, and helping the patient weigh the potential benefits against possible risks and burdens. Some key questions to ask include: What is the purpose of this trial? What treatments are involved and how are they given? What are the possible side effects? How often are appointments required? Is there a chance of receiving a placebo (an inactive treatment)?

Understanding the structure of clinical trials helps families know what to expect. Most cancer clinical trials are divided into phases. Phase I trials test a new treatment in a small group of people to evaluate safety and determine the proper dose. Phase II trials involve more people and assess whether the treatment works against the cancer. Phase III trials compare the new treatment to standard treatments in large groups of patients. Each phase serves a specific purpose in determining whether a treatment should become standard care.

Families play a crucial role in helping with the practical aspects of trial participation. Clinical trials often require frequent visits to the treatment center for assessments, treatments, and monitoring. Family members can help by providing transportation, attending appointments to help remember information and ask questions, keeping track of the appointment schedule, and ensuring the patient takes medications as directed.

Emotional support is equally important. Clinical trial participation can bring both hope and anxiety. There may be uncertainty about whether the treatment is working, worry about side effects, and the stress of frequent medical appointments. Family members can provide reassurance, listen without judgment, help maintain perspective when results are disappointing, and celebrate small victories.

Practical organization helps manage the complexity of trial participation. Families might create a system for tracking appointments, medications, and side effects. Keeping a journal or using a smartphone app to record symptoms, questions for doctors, and important information shared during appointments can be invaluable. Having all this information organized makes it easier to communicate with the medical team.

Financial considerations deserve attention as well. While the experimental treatment itself is usually provided at no cost in clinical trials, there may be other expenses such as travel to the treatment center, parking, lodging if the center is far from home, and time off work. Families should ask about what costs the trial covers and what the patient will be responsible for, and explore whether financial assistance is available for trial-related expenses.

If the patient experiences side effects from the trial treatment, families should know when to seek help. The trial team will provide specific instructions about which symptoms require immediate attention. In general, severe symptoms like difficulty breathing, chest pain, severe bleeding, signs of infection like fever, or extreme weakness should prompt an immediate call to the trial team or a visit to the emergency room.

It’s important to remember that patients have the right to leave a clinical trial at any time, for any reason, without affecting their future care. If the burdens of participation become too great, if side effects are intolerable, or if the patient simply changes their mind, they can withdraw. Family members should support the patient’s decision either way, understanding that choosing to continue or withdraw from a trial is the patient’s choice to make.

⚠️ Important
Supporting someone through a clinical trial is a team effort. Regular communication with the trial team, honest conversations within the family about needs and limitations, and taking care of caregivers’ own health and well-being are all essential. Caregivers who are exhausted or overwhelmed cannot provide effective support, so accepting help from others and taking breaks when possible is not selfish—it’s necessary.

Finding clinical trials for metastatic liposarcoma requires some research. Family members can help by searching clinical trial databases with the patient. Major resources include ClinicalTrials.gov, a comprehensive database of trials worldwide, and the websites of major cancer centers that specialize in sarcoma treatment. The patient’s oncologist can also provide guidance about suitable trials and may even be conducting trials at their institution.

Because liposarcoma is rare, there may not be trials specifically for this cancer in every region. However, some trials accept patients with various types of soft tissue sarcomas, and the patient may be eligible for these broader studies. Families should ask about any trial that seems potentially relevant, as eligibility criteria can be complex.

Throughout the trial experience, maintaining realistic expectations helps. Clinical trials testing new treatments may or may not benefit the individual patient—that’s why the research is being done. However, participation contributes to knowledge that may help future patients, and for many families, this sense of contributing to something larger provides meaning even when outcomes are uncertain.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of metastatic liposarcoma, based only on the provided sources:

  • Trabectedin (Yondelis) – An alkylating drug that binds to DNA and is approved for unresectable or metastatic liposarcoma in patients who have received prior anthracycline-containing therapy[11][9]
  • Eribulin (Halaven) – A microtubule inhibitor approved for unresectable or metastatic liposarcoma in patients who have received prior anthracycline-containing therapy[11]
  • Doxorubicin – An anthracycline chemotherapy drug used as first-line treatment for metastatic soft tissue sarcomas including liposarcoma[9][19]
  • Ifosfamide – A chemotherapy drug often combined with doxorubicin for metastatic liposarcoma, though it may increase side effects[9][19]
  • Dacarbazine – A chemotherapy option that may be considered for certain liposarcoma subtypes[9][19]

Ongoing Clinical Trials on Liposarcoma metastatic

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated drugs:
    Germany
  • Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

    Not recruiting

    2 1 1 1
    Czechia Slovakia

References

https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma/types/liposarcoma

https://www.ncbi.nlm.nih.gov/books/NBK538265/

https://www.mayoclinic.org/diseases-conditions/liposarcoma/symptoms-causes/syc-20352632

https://my.clevelandclinic.org/health/diseases/21142-liposarcoma

https://link.springer.com/chapter/10.1007/978-3-030-93084-4_58

https://pmc.ncbi.nlm.nih.gov/articles/PMC6011058/

https://sarcomaoncology.com/types-of-sarcoma/soft-tissue-sarcomas/liposarcoma/

https://sarcoma.org.uk/about-sarcoma/what-is-sarcoma/types-of-sarcoma/liposarcoma/dedifferentiated-liposarcoma/

https://pmc.ncbi.nlm.nih.gov/articles/PMC5715199/

https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma/types/liposarcoma

https://emedicine.medscape.com/article/1102007-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC3730323/

https://my.clevelandclinic.org/health/diseases/21142-liposarcoma

https://www.mdanderson.org/cancerwise/liposarcoma-survivor–cancer-won-t-stop-me-from-achieving-my-goals.h00-159227301.html

https://my.clevelandclinic.org/health/diseases/21142-liposarcoma

https://sarcomaoncology.com/types-of-sarcoma/soft-tissue-sarcomas/liposarcoma/

https://www.cancer.org/cancer/types/soft-tissue-sarcoma/after-treatment/followup.html

https://www.ummhealth.org/health-library/liposarcoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC8038736/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

Can metastatic liposarcoma be cured?

Metastatic liposarcoma is very difficult to cure, but treatments can help control the disease, relieve symptoms, and extend life. The median survival for metastatic soft tissue sarcomas is typically 12 to 17 months, though some patients live longer, especially with newer treatments[9][19]. In select cases where metastases are limited to one or two spots, surgical removal combined with other treatments may offer longer-term control.

What is the difference between local recurrence and metastasis?

Local recurrence means the cancer has returned in or near the same place where it was originally removed, while metastasis means cancer cells have traveled through the bloodstream or lymphatic system to grow in distant organs or tissues. Local recurrence is common with liposarcoma, occurring in 10% to 75% of cases depending on subtype, even many years after surgery[2][8]. Metastatic disease generally has a more serious prognosis than local recurrence.

Why does liposarcoma spread to unusual places like the spine instead of just the lungs?

Different liposarcoma subtypes have different spreading patterns based on their biological characteristics. Myxoid-round cell liposarcoma in particular tends to spread to soft tissue areas, bones including the spine and pelvis, and retroperitoneal fat rather than to the lungs[5][6]. Scientists believe this unusual pattern may be related to how these specific cancer cells interact with different tissues in the body, though the exact mechanisms are still being studied.

Are there different chemotherapy options for different types of liposarcoma?

Yes, treatment response varies significantly by liposarcoma subtype. Myxoid liposarcoma is considered relatively chemosensitive, particularly to anthracyclines like doxorubicin and to trabectedin[9][11]. Well-differentiated and dedifferentiated liposarcomas tend to be less responsive to chemotherapy[11]. The standard first-line treatment for most metastatic liposarcomas is doxorubicin, sometimes combined with ifosfamide, and newer drugs like trabectedin and eribulin are approved for patients who have tried anthracyclines[9][11].

How often will I need scans and follow-up appointments after treatment for metastatic liposarcoma?

Follow-up schedules vary based on your specific situation, treatment received, and subtype of liposarcoma. Generally, you’ll have regular appointments that include physical examinations and imaging studies like MRI or CT scans to look for signs of disease progression or recurrence[8][17]. Your sarcoma clinical nurse specialist should provide you with a specific follow-up schedule. Because liposarcoma can recur many years after initial treatment, long-term monitoring is important even for patients who seem to be doing well.

🎯 Key takeaways

  • The prognosis for metastatic liposarcoma depends heavily on which subtype you have—well-differentiated cannot spread, while pleomorphic is highly aggressive.
  • Local recurrence is a major concern even decades after surgery, with well-differentiated liposarcoma recurring in about 10% of cases up to 25 years later.
  • Lungs are the most common metastatic site for most sarcomas, but myxoid liposarcoma prefers unusual locations like the spine and fat pads.
  • New FDA-approved drugs like trabectedin and eribulin offer additional treatment options after standard chemotherapy stops working.
  • Living with metastatic liposarcoma requires adapting to physical limitations, managing symptoms, and finding new ways to maintain quality of life.
  • Clinical trials provide access to innovative treatments not yet widely available and contribute to knowledge that helps future patients.
  • Family support plays a crucial role in managing practical logistics, providing emotional support, and helping patients navigate complex treatment decisions.
  • Complications can include breathing difficulties, spinal cord compression, bowel obstruction, and pain that significantly affects daily functioning.